This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
Recent articles:
- Wang R et al. “Involvement of mitogen-activated protein kinases and peroxisome proliferator-activated receptor γ in monosodium urate crystal-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.” Int J Mol Med. 2012 May;29(5):877-82. PMID 22366735
- Aschen S et al. “Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes.” Plast Reconstr Surg. 2012 Apr;129(4):838-47. PMID 22456356
- Montero TD et al. “PPARα and PPARγ regulate the nucleoside transporter hENT1.” Biochem Biophys Res Commun. 2012 Mar 9;419(2):405-11. PMID 22349506
- Charytonowicz E et al. “PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma.” J Clin Invest. 2012 Mar 1;122(3):886-98. PMID 22293175
- Alsaleh A et al. “PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations.” J Nutrigenet Nutrigenomics. 2011;4(6):354-66. PMID 22378291
- Bernardes A et al. “Low-resolution molecular models reveal the oligomeric state of the PPAR and the conformational organization of its domains in solution.” PLoS One. 2012;7(2):e31852. PMID 22363753
- Panasyuk G et al. “PPARγ contributes to PKM2 and HK2 expression in fatty liver.” Nat Commun. 2012 Feb 14;3:672. PMID 22334075
- Kim HH et al. “Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma.” World J Gastroenterol. 2012 Feb 14;18(6):557-62. PMID 22363123
- Devi MS et al. “Angiogenic response of advanced glycation end products (AGEs) involves PPARgamma.” Indian J Biochem Biophys. 2012 Feb;49(1):18-24. PMID 22435140
- Chen J et al. “[Hepatitis C virus core protein upregulates the transcription of PCK1 through FOXO1/PGC-1alpha pathway].” Wei Sheng Wu Xue Bao. 2012 Jan;52(1):52-9. PMID 22489460
Top Pubmed articles linked to gene PPARG matching any search term:
- Lee YJ et al. “Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis.” Proc Natl Acad Sci U S A. 2012 Aug 6;. PMID 22869740
- Qiang L et al. “Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ.” Cell. 2012 Aug 3;150(3):620-32. PMID 22863012
- Huang C et al. “Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.” Hum Mol Genet. 2012 Aug 3;. PMID 22833456
- Lee HR et al. “Red Liriope platyphylla contains a large amount of polyphenolic compounds which stimulate insulin secretion and suppress fatty liver formation through the regulation of fatty acid oxidation in OLETF rats.” Int J Mol Med. 2012 Jul 27;. PMID 22842959
- Lee EY et al. “Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.” Toxicol Lett. 2012 Jul 27;. PMID 22842585
- Rahigude AB et al. “Possible therapeutic potential of berberine in diabetic osteopathy.” Med Hypotheses. 2012 Jul 26;. PMID 22840327
- Lee MY et al. “Peroxisome Proliferator-Activated Receptor Delta Agonist Attenuates Hepatic Steatosis by Anti-inflammatory Mechanism.” Exp Mol Med. 2012 Jul 24;. PMID 22824914
- Sabatino L et al. “PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.” PPAR Res. 2012;2012:687492. PMID 22848209
- Sierra H et al. “Prenatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Adult Metabolic Phenotype.” PPAR Res. 2012;2012:604216. PMID 22829803
- Adi NC et al. “Influence of Diet on Visceral Adipose Remodeling in NONcNZO10 Mice With Polygenic Susceptibility for Type 2 Diabetes.” Obesity (Silver Spring). 2012 Jul 3;. PMID 22858798
- Garaulet M et al. “PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet.” Mol Nutr Food Res. 2011 Dec;55(12):1771-9. PMID 22102511
- Yilmaz-Aydogan H et al. “Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.” Mol Cell Biochem. 2011 Dec;358(1-2):355-63. PMID 21833536
- Flachsbart F et al. “Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.” Mutat Res. 2010 Dec 10;694(1-2):13-9. PMID 20800603
- Hsieh MC et al. “Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus.” Metabolism. 2010 Aug;59(8):1139-44. PMID 20045142
- Voight BF et al. “Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.” Nat Genet. 2010 Jul;42(7):579-89. PMID 20581827
- Chae SJ et al. “Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome.” Gynecol Obstet Invest. 2010;70(1):1-7. PMID 20130411
- Lee YC et al. “Prediction of successful weight reduction after laparoscopic adjustable gastric banding.” Hepatogastroenterology. 2009 Jul-Aug;56(93):1222-6. PMID 19760975
- Cho YW et al. “Histone methylation regulator PTIP is required for PPARgamma and C/EBPalpha expression and adipogenesis.” Cell Metab. 2009 Jul;10(1):27-39. PMID 19583951
- Chello M et al. “Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.” Diabetes Metab Res Rev. 2009 Jul;25(5):420-6. PMID 19405075
- Erdogan M et al. “The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.” Diabetes Res Clin Pract. 2007 Dec;78(3):355-9. PMID 17681394